Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
---|
01/09/2003 | WO2003003012A1 Identification of interacting molecules |
01/09/2003 | WO2003002498A1 Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives |
01/09/2003 | US20030008882 Proteomimetic compounds and methods |
01/09/2003 | US20030008361 Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acids |
01/09/2003 | US20030007927 Complexing drug to leukotrienes at infection, inflammation site |
01/08/2003 | EP0973515B1 Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
01/08/2003 | CN1390191A Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
01/08/2003 | CN1389449A Electron-level ammonium citrate and its production process |
01/08/2003 | CN1098246C Complexing extraction process of purifying glyoxalic acid |
01/07/2003 | US6504036 2- and 2.5-substituted phenylketoenols |
01/07/2003 | CA2124784C Pentanoic acid derivatives |
01/03/2003 | WO2003000658A1 PROCESS FOR THE PREPARATION OF A HIGHLY PURE PHARMACEUTICAL INTERMEDIATE, 4-(CYCLOPROPYLCARBONYL)-α,α-DIMETHYLPHENYLACETIC ACID |
01/03/2003 | WO2003000637A1 PROCESS FOR PREPARATION OF α,α-BIS(HYDROXYMETHYL)- CARBOXYLIC ACIDS |
01/03/2003 | WO2003000636A1 Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid |
01/02/2003 | US20030004375 Stripping acidulated slurry comprising lactic acid, calcium lactate, and calcium sulfate |
01/02/2003 | US20030003115 Cosmetics, dermatology |
01/02/2003 | EP1270737A1 Preincubation assay method |
01/02/2003 | EP1267822A2 Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light |
01/02/2003 | EP0705245B1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
12/31/2002 | USRE37947 Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof |
12/27/2002 | WO2001041543A8 Pesticidal activity of functionalized alkenes |
12/26/2002 | US20020198407 Antiallergy agents and bronchodilators |
12/25/2002 | CN1387505A Compositions contg. hydroxyeicosatetraenoic acid derivs, and methods of use in treating dry eye disorders |
12/25/2002 | CN1387504A Omega-chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for treatment of dry eye |
12/25/2002 | CN1387503A Hydroxyeicosatetraenoate salts, composition and method of use in treating dry eye disorders |
12/25/2002 | CN1387502A 15-hydroxyeicosatetraenoic acid-related compounds and methods of use |
12/24/2002 | US6498269 Method for the oxidation of aldehydes, hemiacetals and primary alcohols |
12/24/2002 | US6498187 Fatty acid synthase inhibitors |
12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
12/19/2002 | WO2002100813A2 Modulators of peroxisome proliferator activated receptors |
12/19/2002 | WO2002100812A1 Carboxylic acid derivative and salt thereof |
12/19/2002 | WO2002100341A2 Compounds for the treatment of metabolic disorders |
12/19/2002 | WO2002072858A3 Degradation of epothilones and ethynyl substituted epothilones |
12/19/2002 | US20020193578 Compounds having activity as inhibitors of cytochrome P450RAI |
12/19/2002 | US20020193436 Inhibit digestion by terminating or blocking synthesis of digestive enzymes by activating trypsin modulating oostatic factor receptor |
12/19/2002 | US20020193291 Treating NIDDM with RXR agonists |
12/19/2002 | US20020193269 As precursors for organoleptic agents, such as fragrances, and masking agents and for antimicrobial agents |
12/19/2002 | CA2449256A1 Modulators of peroxisome proliferator activated receptors |
12/18/2002 | EP1266889A2 Polyoxyalkylene substituted and bridged triazine and benzotriazole derivatives |
12/18/2002 | EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
12/18/2002 | EP1265839A1 Compounds active at the glucocorticoid receptor |
12/18/2002 | EP1265838A1 Novel fatty acid analogous |
12/17/2002 | US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
12/17/2002 | CA2204616C Ppar gamma antagonists for treating obesity |
12/12/2002 | WO2002098840A1 Carboxylic acid derivative and medicine comprising salt or ester of the same |
12/12/2002 | WO2002098220A2 Pesticidal activity of functionalized alkenes |
12/12/2002 | US20020188136 Pesticides and herbicides |
12/12/2002 | US20020187231 Treated with active carbon. |
12/11/2002 | EP0907632B1 Inhibition of matrix metalloproteases by substituted phenethyl compounds |
12/11/2002 | CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents |
12/11/2002 | CN1384090A Extraction process of tanshin general phenolic acid and its prepn and use |
12/10/2002 | US6492424 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
12/10/2002 | US6492423 Hepatitis c and b viricides |
12/10/2002 | US6491983 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
12/05/2002 | US20020183285 Compounds having activity as inhibitors of cytochrome P450RAI |
12/05/2002 | DE10232967A1 Oxidation synthesizing reactor for e.g. synthesis of phthalic acid anhydride, comprises diagonal-action impeller wheel with heat medium throttle gap parallel to shaft |
12/04/2002 | EP1261657A2 Poly(3-cyclopropyl-3-hydroxypropionate) and processes for its preparation and derivatives thereof |
12/04/2002 | EP1261574A2 Process for the recovery of organic acids from aqueous solutions |
12/03/2002 | US6489508 Method for purifying lactic acid |
12/03/2002 | US6489494 Uses of kombic acid as an antioxidant |
11/28/2002 | WO2002094756A1 Synthesis of 4-phenylbutyric acid |
11/28/2002 | WO2002094255A1 Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate |
11/28/2002 | WO2002012155A3 Process for the preparation of chiral 1,4-diaryl-2-fluoro-2-butenes |
11/27/2002 | EP1260504A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives |
11/27/2002 | EP1259474A1 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
11/27/2002 | EP1214328A4 Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions |
11/27/2002 | EP0825982B1 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides |
11/27/2002 | EP0783303B1 Use of aromatic halides for treating mammalian cell proliferation |
11/27/2002 | EP0585267B1 Herpesvirus particle preparation and vaccine |
11/27/2002 | CN1382121A C16 unsaturated FP-selective prostaglandins analogs |
11/27/2002 | CN1381436A Process for synthesizing tartaric acid from maleic acid |
11/27/2002 | CN1094903C Cobaltous oxide (II) containing meallic cobalt, method for producing the same and use thereof |
11/26/2002 | US6486343 Substituted phenyl keto enols as pesticides and herbicides |
11/26/2002 | US6486325 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds |
11/22/2002 | WO2001090062A2 Method for the production of trifluoroethoxy-substituted benzoic acids |
11/22/2002 | CA2409853A1 Method for the production of trifluoroethoxy-substituted benzoic acids |
11/21/2002 | WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii |
11/21/2002 | WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
11/21/2002 | CA2446747A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii |
11/21/2002 | CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
11/20/2002 | EP1257524A1 A process for the preparation of salts of l-carnitine and alkanoyl l-carnitine with mucic acid |
11/20/2002 | EP1257264A1 Estrogen receptor modulators |
11/20/2002 | CN1094483C 加氢甲酰化方法 Hydroformylation process |
11/19/2002 | US6482979 Perfluorinated acid fluorides and preparation thereof |
11/19/2002 | US6482947 Substituted (hetero) aryl compounds, process for their preparation, agents containing them and their use as safeners |
11/19/2002 | CA2115144C Macromonomers having reactive side groups |
11/14/2002 | WO2002090312A1 Process for preparing carboxylic acids and derivatives thereof |
11/14/2002 | WO2002090311A1 Process for the removal of undesired flavour and odour components from potassium lactate |
11/14/2002 | WO2002089806A1 Heterobicycles fkbp-ligands |
11/14/2002 | WO2002089738A2 Proteomimetic compounds and methods |
11/14/2002 | CA2446795A1 Sulfamide, sulfamate, sulfonamide, urea, amide, alpha, alpha-difluoro amide oxalyl diamide, and heterobicycles fkbp-binding ligands |
11/14/2002 | CA2446638A1 Process for preparing carboxylic acids and derivatives thereof |
11/14/2002 | CA2446380A1 Proteomimetic compounds and methods |
11/13/2002 | EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils |
11/13/2002 | CN1379748A Process for preparing optically active alpha-hydroxy acids and derivatives thereof |
11/12/2002 | US6479663 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
11/12/2002 | US6479470 Naag and naaladase have been implicated in several pathological conditions relating to glutamate abnormalities and neurotoxicity |
11/12/2002 | US6478965 Recovery of fermentation salts from dilute aqueous solutions |
11/07/2002 | WO2001036365A3 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
11/07/2002 | US20020165340 Process for preserving resin catalyst for addition reaction of alkylene oxide and utilization of this process |